logo

LYEL

Lyell Immunopharma·NASDAQ
--
--(--)
--
--(--)

LYEL fundamentals

Lyell Immunopharma (LYEL) released its earnings on Aug 12, 2025: revenue was 8.00K (YoY -38.46%), beat estimates; EPS was -2.89 (YoY +19.72%), beat estimates.
Revenue / YoY
8.00K
-38.46%
EPS / YoY
-2.89
+19.72%
Report date
Aug 12, 2025
Earnings Call
4:00 PM on Aug 12, 2025
Meeting link.
EPS
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-29.4-3.5417-7-5.5371-1.9-5.6-0.6-3.6-5.2-4-4.2-4.7861-3.6-3.4-8.9-1.86-2.89
Forecast
-7.5-9.4-5.4087-5.55-4.383-6.2218-4.55-5.15-5.25-4.84-4.6-4.4-3.95-3.9-3.4-3.6-3.52
Surprise
-292.00%
+62.32%
-29.42%
+0.23%
+56.65%
+9.99%
+86.81%
+30.10%
+0.95%
+17.36%
+8.70%
-8.77%
+8.86%
+12.82%
-161.76%
+48.33%
+17.90%
Revenue
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
2.63M2.75M2.82M553.00K35.74M2.80M48.39M65.00K27.00K25.00K13.00K3.00K13.00K34.00K11.00K7.00K8.00K
Forecast
2.31M2.88M2.64M776.50K17.87M1.80M16.13M-17.50K18.00K6.25K3.25K1.00K3.25K0004.00K
Surprise
+13.57%
-4.26%
+6.79%
-28.78%
+100.00%
+55.56%
+200.00%
+471.43%
+50.00%
+300.00%
+300.00%
+200.00%
+300.00%
0.00%
0.00%
0.00%
+100.00%

Earnings Call